China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Short Interest Update

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) saw a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 262,000 shares, a growth of 263.4% from the November 30th total of 72,100 shares. Based on an average daily volume of 880,400 shares, the short-interest ratio is currently 0.3 days. Currently, 7.6% of the shares of the stock are short sold.

China SXT Pharmaceuticals Price Performance

SXTC stock traded down $0.03 during midday trading on Friday, reaching $0.42. The company had a trading volume of 830,005 shares, compared to its average volume of 841,468. China SXT Pharmaceuticals has a 1-year low of $0.30 and a 1-year high of $6.39. The stock has a 50 day moving average price of $0.45 and a 200-day moving average price of $0.74. The company has a quick ratio of 1.51, a current ratio of 1.60 and a debt-to-equity ratio of 0.01.

China SXT Pharmaceuticals Company Profile

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.